Eisai
4523.T
#2303
Rank
NZ$14.25 B
Marketcap
NZ$50.52
Share price
-1.71%
Change (1 day)
5.95%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: NZ$0.91 Billion

According to Eisai's latest financial reports the company's current earnings are NZ$5.06 Billion. In 2023 the company made an earning of NZ$0.91 Billion, an increase over its 2022 earnings that were of -NZ$39.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023NZ$0.91 B-2404.04%
2022-NZ$39.62 Million-103.6%
2021NZ$1.10 B-39.81%
2020NZ$1.82 B7.44%
2019NZ$1.70 B17.22%
2018NZ$1.45 B86.16%
2017NZ$0.78 B-23.52%
2016NZ$1.02 B26.97%
2015NZ$0.80 B22.3%
2014NZ$0.65 B-46.07%
2013NZ$1.21 B-21.85%
2012NZ$1.55 B-20.59%
2011NZ$1.96 B-8.91%
2010NZ$2.15 B19.21%
2009NZ$1.80 B